While catheter ablation is currently a common treatment approach, there has been advances in stereotactic radioablation for certain arrythmias.  This technique is commonly used for solid tumors and has been applied with success in management of difficut to treat Ventricular Tachycardia and Atrial Fibrillation.

Direct to consumer options for monitoring of heart rate and heart rate variability has become increasingly prevalant using smart phones and smart watches.  These monitoring systems have become increasingly validated and may help provide early identification for those at risk for a serious arrythmia such as atrial fibrillation.